Ex vivo apoptotic and autophagic influence of an estradiol analogue on platelets
Open Access
- 1 December 2015
- journal article
- research article
- Published by Springer Nature in Experimental Hematology & Oncology
- Vol. 5 (1) , 1-10
Abstract
Platelets are known contributors to the vascularization, metastasis and growth of tumors. Upon their interaction with cancer cells they are activated resulting in degranulation and release of constituents. Since the apoptotic- and autophagic effects of 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10)16-tetraene (ESE-16) has been shown to occur in vitro and this compound was designed to bind to carbonic anhydrase II (CAII), the possible occurrence of these cell death mechanisms in platelets as circulatory components, is of importance. Scanning electron microscopy was used to assess morphological changes in platelets after exposure to ESE-16. The possible apoptotic- and autophagic effect of ESE-16 in platelets was also determined by means of flow cytometry through measurement of Annexin V-FITC, caspase 3 activity, autophagy related protein 5 levels and light chain 3-I to light chain 3-II conversion. Scanning electron microscopy revealed no changes in ESE-16-treated platelets when compared to vehicle-treated samples. Apoptosis detection by Annexin V-FITC and measurement of caspase 3 activity indicated that there was no increase in apoptosis when platelets were exposed to ESE-16. The incidence of autophagy by measurement of autophagy related protein 5 levels and light chain 3-I to light chain 3-II conversion showed that exposure to ESE-16 did not cause the incidence of autophagy in platelets. This is the first ex vivo study reporting on involvement of apoptosis- and autophagy-related targets in platelets after exposure to ESE-16, warranting further investigation in platelets of cancer patients.Keywords
Funding Information
- Cancer Association of South Africa (A0V741, AOW228)
- South African Medical Research Council (AOW110)
- Struwig Germeshuysen Trust (AONO74)
- National Research Foundation (N00375, N00591)
This publication has 46 references indexed in Scilit:
- Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer CellsPLOS ONE, 2013
- Molecular crosstalk between apoptosis and autophagy induced by a novel 2-methoxyestradiol analogue in cervical adenocarcinoma cellsCancer Cell International, 2013
- In Vitro Evaluation of ESE-15-ol, an Estradiol Analogue with Nanomolar Antimitotic and Carbonic Anhydrase Inhibitory ActivityPLOS ONE, 2012
- Differential expression of MMP-2 and MMP-9 activity in megakaryocytes and plateletsBlood, 2011
- The Role of Autophagy in Cancer: Therapeutic ImplicationsMolecular Cancer Therapeutics, 2011
- PlateletsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Autophagy in health and disease. 5. Mitophagy as a way of lifeAmerican Journal of Physiology-Cell Physiology, 2010
- The role of the intrinsic apoptosis pathway in platelet life and deathJournal of Thrombosis and Haemostasis, 2009
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Crystal structure of human carbonic anhydrase II at 1.95 Å resolution in complex with 667-coumate, a novel anti-cancer agentBiochemical Journal, 2005